NASDAQ$ALHC
Alignment Healthcare Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Alignment Healthcare's second quarter showcased the replicability of their model and resulted in one of their best quarters since taking the company public.
Alignment Healthcare reported strong second-quarter results, exceeding guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company's medical benefits ratio was the lowest since the IPO.
- The second quarter marks the company's lowest medical benefits ratio since the IPO.
- The company beat guidance on four key performance indicators: membership, revenue, adjusted gross profit and adjusted EBITDA.
- The company expects to build upon this momentum and remain confident in their team’s ability to achieve their full-year financial targets.
- Planned 2023 market expansions are subject to regulatory approval.
Headline financials
Revenue & EPS history
Alignment Healthcare · Revenue · Quarterly
$366M
Revenue by segment
Alignment Healthcare · $265M total across 2 segments · Q1 2021
- Earned premiums$265M+18.0%100.0%
- Other revenue$82K—0.0%
Forward guidance
The company is confident in their team’s ability to achieve their full-year financial targets.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+1.8%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+2.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+27.0%
Q1 2024
Best reaction
-16.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -15.7% | -29.5% | |
| Q4 2025 | -5.8% | -7.5% | -18.6% | |
| Q3 2025 | -1.9% | -0.4% | +12.2% | |
| Q1 2025 | -7.7% | -7.5% | -8.3% | |
| Q4 2024 | +16.5% | +17.4% | +35.9% | |
| Q3 2024 | +1.6% | +12.2% | +11.2% | |
| Q2 2024 | +2.3% | +4.9% | +3.1% | |
| Q1 2024 | +27.0% | +31.6% | +51.0% | |
| Q4 2023 | -8.9% | -9.2% | -20.1% | |
| Q3 2023 | -9.6% | -7.2% | +10.5% | |
| Q2 2023 | +7.5% | +10.5% | -4.2% | |
| Q1 2023 | +3.5% | +11.3% | -5.1% | |
| Q4 2022 | -16.4% | -20.9% | -35.2% | |
| Q3 2022 | -3.1% | -3.3% | -2.7% | |
| Q2 2022 | +10.4% | +4.3% | -8.7% | |
| Q1 2022 | -7.0% | -18.8% | +6.8% | |
| Q4 2021 | +10.7% | +8.0% | +39.7% | |
| Q3 2021 | +10.6% | +6.1% | -26.7% | |
| Q2 2021 | -8.5% | -4.8% | -11.2% | |
| Q1 2021 | +6.8% | +13.3% | +27.6% | |
| Q4 2020 | +6.8% | +13.3% | +27.6% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro